Prior Autoimmune Disease and Risk of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Systematic Review

201463 citationsReviewbronze Open Access

Authors

Charlene M. McShane · National Cancer Institute

Liam Murray · National Cancer Institute

Ola Landgren · National Cancer Institute

Michael O’Rorke · National Cancer Institute

Neha Korde · University of Malaya

Andrew T. Kunzmann · National Cancer Institute

Roshidi Ismail ·

Abstract

Underlying mechanisms of autoimmune diseases, general immune dysfunction, and/or treatment of autoimmune diseases may be important in the pathogenesis of MGUS/multiple myeloma.

Topics & Keywords

Multiple Myeloma Research and Treatments Chronic Lymphocytic Leukemia Research Peripheral Neuropathies and Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer Epidemiology Biomarkers & Prevention

Volume 23, Issue 2, pp. 332-342

DOI: 10.1158/1055-9965.epi-13-0695

Field-Weighted Citation Impact: 3.04